(3S)-1-(2'-(DIMETHYLPHOSPHANYL)-PHENYL)-2,5-DIOXA-3-PHENYL-HEXAN
Compound with spectra: 2 NMR
| SpectraBase Compound ID | 1cbFeB3QqTl |
|---|---|
| InChI | InChI=1S/C36H55O2P/c1-25(2)31-19-17-27(5)21-35(31)39(36-22-28(6)18-20-32(36)26(3)4)34-16-12-11-15-30(34)23-38-33(24-37-7)29-13-9-8-10-14-29/h8-16,25-28,31-33,35-36H,17-24H2,1-7H3/t27-,28-,31+,32+,33-,35-,36-/m0/s1 |
| InChIKey | KKBHWFOITLVMIQ-ZKJRBWSXSA-N |
| Mol Weight | 550.8 g/mol |
| Molecular Formula | C36H55O2P |
| Exact Mass | 550.393968 g/mol |
| Enantiomer InChIKey | KKBHWFOITLVMIQ-LSTDUJRDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(+)-1-(Dimenthylphosphanyl)-2-(diphenylphosphanyl)benzene
2-Phenyl-4,5-dimethyl-6-(ethoxycarbonyl)-2-phosphabicyclo[3.1.0]hexa-3-ene
6-ENDO-HYDROXY-1,2-DIPHENYL-1-PHOSPHONIATRICYCLO-[3.3.1.1(3,7)]-DECANE-IODIDE
TERT.-BUTYL-(1S,2S,3R,R(P))-6,6-DIMETHYL-3-(METHYLPHENYLPHOSPHANYL)-BICYCLO-[3.1.1]-HEPTANE-2-CARBOXYLATE
(1R,6R,9R)-9-[ (S)-.alpha.-Methoxy-.alpha.-trifluoromethylphenylacetoxy]-7-oxabicyclo[4.3.0]non-4-en-8-one
N-Ethyl-3,4-methylenedioxyamphetamine PFO
3-pyridinecarbonitrile, 2-[[(2-chloro-6-fluorophenyl)methyl]thio]-4-(4-methoxyphenyl)-6-phenyl-
2-Amino-3-methyl-5-(2',3',5'-tri-O-benzyl-.beta.,D-ribofuranosyl)pyridine
4-Bromo-N-tosylindole-3-carbaldehyde
5-acetyl-4-(2-furyl)-2-mercapto-6-methylnicotinonitrile
| Title | Journal or Book | Year |
|---|---|---|
| Enantioselektive Katalyse, 121. Mitt. [1]: Chirale Phosphanliganden mit zusätzlichen Sauerstoffunktionalitäten | Monatshefte für Chemie / Chemical Monthly | 1998 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.